Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 3Phase 2 2

Status

Recruiting 8Active not recruiting 5Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 8

Study Type

Interventional 8

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Head & Neck 2

Conditions

Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2

Interventions

Specimen Handling 125pembrolizumab 123Magnetic Resonance Spectroscopy 108Carboplatin 89Cyclophosphamide 80Biopsy 69Cisplatin 67Paclitaxel 61Bevacizumab 56Gemcitabine 54Nivolumab 49fludarabine 48Dexamethasone 41Rituximab 39Pemetrexed 39Fluorouracil 39Radiotherapy 37Doxorubicin 37atezolizumab 36Docetaxel 36Leucovorin 35Oxaliplatin 32Capecitabine 32venetoclax 31Temozolomide 29Prednisone 29durvalumab 27Standard of Care 27Radiation 27Letrozole 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Recruiting × amivantamab × 30 days × Clear all
NCT05379595 2026-06-05

OrigAMI-1

Janssen Research & Development, LLC

Phase 1/2 Recruiting
225 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05498428 2026-06-05

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting
520 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06385080 2026-06-05

OrigAMI-4

Janssen Research & Development, LLC

Phase 1/2 Recruiting
287 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06662786 2026-06-05

OrigAMI-2

Janssen Research & Development, LLC

Phase 3 Recruiting
1,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06667076 2026-06-05

COPERNICUS

Janssen Research & Development, LLC

Phase 2 Recruiting
480 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06750094 2026-06-05

OrigAMI-3

Janssen Research & Development, LLC

Phase 3 Recruiting
700 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07227025 2026-06-05

KaRAnaSa

Janssen Research & Development, LLC

Phase 1/2 Recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07276399 2026-06-05

OrigAMI-5

Janssen Research & Development, LLC

Phase 3 Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡